Market map · United States
Precision medicine market map: United States
123 precision medicine startups based in the United States that have raised money in rounds we track, placed in 3 segments by what each says it does. Together they have raised $8.3B; the biggest segment is precision oncology.
123startups on the map
3segments
$8.3Braised between them
Precision oncologymost funded segment
BridgeBio
Guardant Health
ErascaEnliven Therapeutics
Kura Oncology
Treeline Biosciences
BostonGene
Antares Therapeutics
Epic Sciences
Scorpion Therapeutics
OnKure Therapeutics
MOMA TherapeuticsBoundless Bio
Acrivon Therapeutics
Flare Therapeutics
FORE Biotherapeutics
Synnovation Therapeutics
Stipple Bio
Strata Oncology
Nested Therapeutics- CTCelsius Therapeutics
Kinnate Biopharma
Haystack Oncology
Magnet Biomedicine
+33 more
Funding by segment
- Precision oncology$6.5B57
- Companion diagnostics and biomarkers$1.3B48
- Data and AI platforms$446M18
Where they are based
- United States123$8.3B
United StatesFounded
33Earlier
312
413
214
815
416
517
1418
719
1020
1221
822
323
24
125
26
9 without a founding year on record.
Total raised
- Under $1M16
- $1M to $10M34
- $10M to $50M38
- $50M to $250M30
- $250M to $1B4
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
113 of 123 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States123
Startups by country, 1 country in all.
Segment by segment
Precision oncology
57 startups · $6.5B raised
- BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.4B
- Guardant HealthGuardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.United States$800M
- ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$739M
- Kura OncologyKura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.United States$210M
- Treeline BiosciencesTreeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.United States$200M
- BostonGeneBostonGene is a biotechnology company based in Waltham, Massachusetts, founded in 2015.United States$200M
- Antares TherapeuticsAntares Therapeutics, Inc.United States$177M
Companion diagnostics and biomarkers
48 startups · $1.3B raised
Alto NeuroscienceAlto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.United States$270M
SomaLogicSomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.United States$247M
HiFiBiOHiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.United States$105M
Akoya BiosciencesAkoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.United States$94M
Exai BioExai Bio is a biotechnology company based in Palo Alto, California, founded in 2021.United States$68M
QuanterixQuanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.United States$52MCleveland HeartLabCleveland HeartLab is a clinical laboratory and disease management firm, develops biomarker technologies and diagnostic tests.United States$51M
Ellipsis HealthEllipsis Health is an AI healthcare company based in San Francisco, California, founded in 2017 by CEO Mainul Mondal.United States$45M
Data and AI platforms
18 startups · $446M raised
Zephyr AIZephyr AI is a precision medicine and healthcare technology company focused on enhancing drug discovery and clinical trials througUnited States$111M
Character BiosciencesCharacter Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development forUnited States$110M
Beacon BiosignalsBeacon Biosignals is a Boston-based neurotechnology company founded in 2019.United States$97M
OmiciaGlobal healthcare platform for genomics-driven precision medicine.United States$30M
PacegenixPacegenix is a healthcare tech company advancing cardiovascular care with data-driven precision medicine solutions.United States$23M
PrenosisPrenosis Inc.United States$20M
NucleaiNucleai is an AI-powered spatial biology software platform focused on precision medicine.United States$14M
IggboIggbo is a healthcare technology company founded in 2015 and headquartered in Richmond, Virginia.United States$13M
How this map is made. Every startup here has raised money in rounds we track, and is based in United States. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in precision medicine, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More market maps
All mapsMarket mapPrecision medicine market map215 startups · 3 segments · $10BInvestors mapWho invests in precision medicine88 investors · 5 segmentsMarket map · EuropePrecision medicine market map: Europe68 startups · 3 segments · $885MNew waveNew precision medicine startups, founded 2020 on62 startups · 3 segments · $1.8BRaised in 2026Precision medicine startups that raised in 202637 startups · 3 segments · $2.9BMarket map · United KingdomPrecision medicine market map: United Kingdom22 startups · 3 segments · $404M
Who backs precision medicine?
Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.